5,8,11,14-eicosatetraynoic acid has been researched along with Alloxan Diabetes in 3 studies
5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iida, N | 1 |
Iida, R | 1 |
Takeyama, N | 1 |
Tanaka, T | 1 |
Waters, KM | 1 |
Ntambi, JM | 1 |
Myers, TO | 1 |
Messina, EJ | 1 |
3 other studies available for 5,8,11,14-eicosatetraynoic acid and Alloxan Diabetes
Article | Year |
---|---|
Increased platelet aggregation and fatty acid oxidation in diabetic rats.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Adenosine Diphosphate; Animals; Blood Platelets; Carnitine O-Palmit | 1993 |
Polyunsaturated fatty acids inhibit hepatic stearoyl-CoA desaturase-1 gene in diabetic mice.
Topics: 5,8,11,14-Eicosatetraynoic Acid; alpha-Linolenic Acid; Animals; Diabetes Mellitus, Experimental; Die | 1996 |
Depressed arteriolar responsiveness to norepinephrine in streptozotocin-induced diabetes in the rat.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Arachidonic Acid; Arterioles; Blood Glucose; Blood Pressur | 1996 |